CAI vs ED · rev $216.8M vs P/E 18, rev $15.26B
Caris Life Sciences, Inc. Common Stock (CAI) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported CAI revenue for 2025-09-30 was $216.8M. Net income was $24.3M. Revenue was up 19.5% from 2025-06-30 to 2025-09-30. CAI currently screens at market cap $5.22B.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
CAI currently screens at market cap $5.22B. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the CAI and ED stock pages for the full models.
Not investment advice.